🚀 VC round data is live in beta, check it out!
- Public Comps
- Polyrizon
Polyrizon Valuation Multiples
Discover revenue and EBITDA valuation multiples for Polyrizon and similar public comparables like Geratherm Medical, Episurf Medical, Iridex, Inspira Technologies and more.
Polyrizon Overview
About Polyrizon
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
Founded
2005
HQ

Employees
6
Website
Sectors
Financials (FY)
EV
$18M
Polyrizon Financials
Polyrizon reported last fiscal year revenue of — and negative EBITDA of ($5M).
In the same fiscal year, Polyrizon generated ($5M) in EBITDA losses and had net loss of ($3M).
Polyrizon P&L
In the most recent fiscal year, Polyrizon reported revenue of — and EBITDA of ($5M).
Polyrizon expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($3M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Polyrizon Stock Performance
Polyrizon has current market cap of $17M, and enterprise value of $18M.
Market Cap Evolution
Polyrizon's stock price is $10.75.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18M | $17M | -4.9% | XXX | XXX | XXX | $-2.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPolyrizon Valuation Multiples
Polyrizon trades at (3.3x) EV/EBITDA.
Polyrizon Financial Valuation Multiples
As of April 11, 2026, Polyrizon has market cap of $17M and EV of $18M.
Equity research analysts estimate Polyrizon's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Polyrizon has a P/E ratio of (5.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV (current) | $18M | XXX | $18M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (3.1x) | XXX | XXX | XXX |
| P/E | — | XXX | (5.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Polyrizon Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Polyrizon Margins & Growth Rates
Polyrizon's revenue in the last fiscal year grew by —.
Polyrizon's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.0M for the same period.
Polyrizon Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 360% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Polyrizon Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Geratherm Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Episurf Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Iridex | XXX | XXX | XXX | XXX | XXX | XXX |
| Inspira Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Clinical Laserthermia | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Polyrizon M&A Activity
Polyrizon acquired XXX companies to date.
Last acquisition by Polyrizon was on XXXXXXXX, XXXXX. Polyrizon acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Polyrizon
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPolyrizon Investment Activity
Polyrizon invested in XXX companies to date.
Polyrizon made its latest investment on XXXXXXXX, XXXXX. Polyrizon invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Polyrizon
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Polyrizon
| When was Polyrizon founded? | Polyrizon was founded in 2005. |
| Where is Polyrizon headquartered? | Polyrizon is headquartered in Israel. |
| How many employees does Polyrizon have? | As of today, Polyrizon has over 6 employees. |
| Who is the CEO of Polyrizon? | Polyrizon's CEO is Tomer Izraeli. |
| Is Polyrizon publicly listed? | Yes, Polyrizon is a public company listed on Nasdaq. |
| What is the stock symbol of Polyrizon? | Polyrizon trades under PLRZ ticker. |
| When did Polyrizon go public? | Polyrizon went public in 2024. |
| Who are competitors of Polyrizon? | Polyrizon main competitors are Geratherm Medical, Episurf Medical, Iridex, Inspira Technologies. |
| What is the current market cap of Polyrizon? | Polyrizon's current market cap is $17M. |
| Is Polyrizon profitable? | No, Polyrizon is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.